Related Experiment Video

Updated: Aug 9, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

A mutant P53 can activate apoptosis through a mechanism distinct from those induced by wild type P53

Ming He1, Paul S Rennie, Visia Dragowska

  • 1The Prostate Centre at Vancouver General Hospital, Vancouver, BC, Canada

FEBS Letters
|June 14, 2002
PubMed

Insights

A common P53 mutation (P53(gly(281))) induces apoptosis similarly to wild-type P53 but via a novel pathway. This gain of function in prostate cancer cells offers new therapeutic insights.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • The P53 tumor suppressor protein is crucial for regulating cell growth and preventing cancer.
  • A frequent mutation at residue 281 (P53(gly(281))) in the DNA binding domain impairs P53's normal function and can confer oncogenic properties.
  • Understanding the precise activity of mutated P53 is vital for developing targeted cancer therapies.

Purpose of the Study:

  • To investigate the functional activity of the P53(gly(281)) mutation in prostate cancer cells.
  • To compare the apoptotic effects of P53(gly(281)) with wild-type P53 (wtP53).
  • To elucidate the specific pathways involved in P53(gly(281))-mediated apoptosis.

Main Methods:

  • Utilized P53-null PC3 human prostate cancer cells.
  • Introduced and expressed both P53(gly(281)) and wtP53 in these cells.
  • Assessed apoptosis induction and its modulation by bcl-2 overexpression.

Main Results:

  • P53(gly(281)) effectively induced apoptosis in PC3 cells, comparable to wtP53.
  • Apoptosis mediated by P53(gly(281)) was not inhibited by bcl-2 overexpression, unlike wtP53-induced apoptosis.
  • This suggests P53(gly(281)) activates an alternative apoptotic pathway.

Conclusions:

  • The P53(gly(281)) mutation, despite potential oncogenic gain, paradoxically activates a distinct, bcl-2-insensitive apoptotic pathway.
  • This finding highlights the complex, context-dependent roles of mutant P53 in cancer.
  • Identifying this alternative pathway could reveal new therapeutic strategies for cancers with P53 mutations.

More Related Videos

Exploring Caspase Mutations and Post-Translational Modification by Molecular Modeling Approaches05:56

Exploring Caspase Mutations and Post-Translational Modification by Molecular Modeling Approaches

Published on: October 13, 2022

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...